• GW Pharmaceuticals and the Government of New South Wales Announce Clinical Trial for Children with Epilepsy
    NSW Premier Mike Baird
  • GW's CEO Justin Gover

News & Views

GW Pharmaceuticals and the Government of New South Wales Announce Clinical Trial for Children with Epilepsy

GW Pharmaceuticals plc and the Government of New South Wales (NSW) Australia, have signed a Memorandum of Understanding (MOU,) to progress a research program for Epidiolex® (cannabidiol or CBD) and cannabidivarin (CBDV) in children with severe, drug resistant childhood epilepsy.

“GW is pleased to have been able to respond to the needs of the New South Wales government and its citizens by establishing this research program for cannabinoid-based medicines in children with treatment resistant epilepsy,” said Justin Gover, GW’s Chief Executive Officer. “As part of this research partnership, GW expects to advance clinical trials in Australia for both Epidiolex and our earlier stage pipeline product CBDV.”

“This confirms NSW’s position as a world leader in cannabinoid research and demonstrates the determination of our Government to ensure we secure these groundbreaking trials,” stated NSW Premier Mike Baird. “Our research and development is driven by compassion for those suffering so we hope that these initiatives will bring relief to many children and their loved ones.”

The NSW Government is providing $3.5 million to the Sydney Children's Hospitals Network to lead the Phase 2 clinical trial of CBDV in children, which is expected to commence in 2016. The agreement also delivers a compassionate access program for Epidiolex for a small number of children who are too sick to participate in a clinical trial, due to the unrelenting nature of their epilepsy. Like CBD, CBDV does not produce the psychoactive effects associated with herbal cannabis. The package is supported through the NSW Government’s $21 million commitment to support medicinal cannabis reforms.


Digital Edition

Lab Asia 31.6 Dec 2024

December 2024

Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...

View all digital editions

Events

Turkchem

Nov 27 2024 Istanbul, Turkey

Smart Factory Expo 2025

Jan 22 2025 Tokyo, Japan

Instrumentation Live

Jan 22 2025 Birmingham, UK

SLAS 2025

Jan 25 2025 San Diego, CA, USA

Arab Health

Jan 27 2025 Dubai, UAE

View all events